Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

History of Gadolinium Toxicity

Last year, 60 experts from around the world gathered at a workshop during the National Institutes of Health. They aimed to bridge the gap between ongoing concern of gadolinium toxicity and the medical community denying it.

About Gadolinium

Gadolinium ToxicityGadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of elements in the periodic table called Lanthanides, the chemical is a rare earth element. Microwave applications, color TV tubes, synthetic gemstones, compact discs, and computer memory typically use the chemical. Also, the medical community uses this chemical element as an injectable contrast agent when patients undergo MRI or MRA scans.
The medical community believes that after they inject the body with this dye, it expels it naturally within a few hours. However, this is not always the case. The chemical agent can also stay in the body for months or years following a single imaging session. Therefore, it causes the body to develop a whole range of debilitating symptoms like brain fog, ligament tightening, balance problems, hair loss, cognitive symptoms and more.

The Rise of Gadolinium Toxicity

Gadolinium-based contrast agents have been a staple in radiology for the past 30 years. In 2006, dangers began to surface as researchers linked the chemical to nephrogenic systemic fibrosis (NSF) in patients with impaired renal function. The FDA added warnings and doctors began to minimize the threat with careful consideration. Even with this disease, the medical community still deny that gadolinium toxicity exists.
Last year, patients received over  36 million MRIs in the United States. Nearly 40% used contrast dyes. Gadolinium agents are so dominant that gadolinium concentration in the surface water of San Francisco Bay has increased in the last 20 years. Yet in 2014 when patients began to complain about side effects of this dye, radiologists dismissed them. They thought gadolinium deposition couldn’t occur in patients with normal renal function. Multiple studies prove this, but the medical community denies it.

Advocate Successes

There have been a few successes in gaining notoriety for gadolinium toxicity. The European Medicines Agency (EMA) recommended that most linear GBCAs be withdrawn from the market. Then, the FDA in December 2017 issued a new class warning and other safety measures for all gadolinium-based contrast agents in response to the public‘s metastasizing concern. It also urged radiologists to “limit GBCA use to circumstances in which additional information provided by the contrast agent is necessary.” However, many medical professionals still don’t educate their patients about the dangers. This is why it is necessary to seek litigation efforts against these manufacturers. They know gadolinium is dangerous, yet unless patients continue to speak against them, it will never be removed from scans.

Free Case Evaluation

eliquis helpA gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have also over 20 years of experience helping consumers injured by unsafe products manufactured by large companies.

×
What Our Clients Are Saying